1 May 2026
Predictors of Left Ventricular Fibrosis in Mitral Annular Disjunction: Cardiac Magnetic Resonance Imaging StudyPublisher siteEchocardiography, Cardiac Valve Diseases and Treatments
Active, last published 2026
In cardiac valve diseases and treatments
Mohamed
Abdelfattah
Scholar“Research focused on Cardiac Valve Diseases and Treatments and adjacent fields.”
Claim Your Profile2
H-index
10
Citations
Mohamed has not officially claimed their profile. If you are Mohamed, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
Expert
UPGRADE
01 · About the work
What I study
ohamed Abdelfattah is a researcher working on Cardiac Valve Diseases and Treatments. A fuller summary will appear once they update their profile.
02 · Reach
Publication output and reach
Mohamed's work has been cited 10 times across 2 active years. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
03 · Research focus
Topics
Cardiac Valve Diseases and Treatments×4Cardiac Imaging and Diagnostics×3Infective Endocarditis Diagnosis and Management×3Gastrointestinal motility and disorders×2Aortic Disease and Treatment Approaches×2
04 · Where I am
Affiliations
Affiliation on published researchKafrelsheikh University, EgyptDrawn from the institution listed on this researcher’s published work.
Research themes (UN SDGs)
05 · Selected work
Recent publications
2 works1 May 2024Open access
LVNC or hyper-trabeculated LV, are we missing something?Publisher siteEP Europace, Cardiac tumors and thrombi
Expert Academic Profiles go further
Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.
Are you Mohamed?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
Free to claim · takes a minute to verify it’s you